Pharmacists and prescribers express ongoing concern about medication prior authorization struggles, but most are willing to ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

Brinsupri is the first approved therapy to address the underlying inflammatory process of non-cystic fibrosis bronchiectasis ...

Sharon Faust, chief pharmacy officer at Navitus Health Solutions and PBMI Innovator Award winner, works to improve the pharmacy benefit system by promoting transparency, educating others about rules, ...

HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, ...

CEO Scott Staszak spoke to Managed Healthcare Executive about the creation of a patient registry and other accomplishments.

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...

An expert discusses how long-term corticosteroid use carries risks of skin atrophy, systemic effects such as adrenal suppression, and area-specific concerns such as increased intraocular pressure near ...

A recent study found major racial disparities in U.S. prescription drug use, with White patients using the most and Black ...

We’ll be back on Monday morning with more fresh content!

Kasey Raetz, Pharm.D., transitioned from working at a small independent pharmacy to leading product and pharma contracting strategy at Express Scripts, earning a PBMI Innovator Award for her creative ...

Originally approved earlier this year for multiple inflammatory conditions, including rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis and COVID-19-related inflammation, ...